Estrella Immunopharma Statistics

Total Valuation

ESLA has a market cap or net worth of $48.64 million. The enterprise value is $46.71 million.

Market Cap	48.64M
Enterprise Value	46.71M

Important Dates

The last earnings date was Monday, May 18, 2026, before market open.

Earnings Date	May 18, 2026
Ex-Dividend Date	n/a

Share Statistics

ESLA has 42.67 million shares outstanding. The number of shares has increased by 5.23% in one year.

Current Share Class	42.67M
Shares Outstanding	42.67M
Shares Change (YoY)	+5.23%
Shares Change (QoQ)	+11.36%
Owned by Insiders (%)	1.88%
Owned by Institutions (%)	2.66%
Float	13.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.24

Current Ratio	0.24
Quick Ratio	0.22
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-271.46%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	251.42%
Weighted Average Cost of Capital (WACC)	9.65%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ESLA has paid $825 in taxes.

Income Tax	825
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.27% in the last 52 weeks. The beta is 0.98, so ESLA's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	+16.27%
50-Day Moving Average	1.37
200-Day Moving Average	1.42
Relative Strength Index (RSI)	35.54
Average Volume (20 Days)	36,997

Short Selling Information

The latest short interest is 147,543, so 0.35% of the outstanding shares have been sold short.

Short Interest	147,543
Short Previous Month	265,805
Short % of Shares Out	0.35%
Short % of Float	1.06%
Short Ratio (days to cover)	0.97

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.25M
Pretax Income	-13.25M
Net Income	-13.25M
EBITDA	n/a
EBIT	-13.25M
Earnings Per Share (EPS)	-$0.35

Full Income Statement

Balance Sheet

The company has $1.93 million in cash and n/a in debt, with a net cash position of $1.93 million or $0.05 per share.

Cash & Cash Equivalents	1.93M
Total Debt	n/a
Net Cash	1.93M
Net Cash Per Share	$0.05
Equity (Book Value)	-5.27M
Book Value Per Share	-0.12
Working Capital	-6.77M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-8.02M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ESLA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.23%
Shareholder Yield	-5.23%
Earnings Yield	-27.24%
FCF Yield	n/a

Analyst Forecast

Price Target	$12.00
Price Target Difference	952.63%
Analyst Consensus	n/a
Analyst Count	0
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2